Scientists at Genentech and SLAC have watched a key human protein change from a form that protects cells to one that kills them, providing valuable new insights to cancer research.

SSRL protein crystallography expert joined research effort that could lead to a safe and effective alternative to chemotherapy.

After working with particle accelerators his entire professional career, Heather Rock Woods’ father placed himself in the path of a beam to fight cancer.

By finding surprising similarities in the way immune system defenders bind to disease-causing invaders, a new study may help scientists develop new treatments.

Researchers have discovered that an Ebola virus protein can transform into three distinct structures with different functions. This rather uncommon property provides new clues for the development of potential drugs for deadly hemorrhagic fever.

Given a year to mature, the Institute for Chemical Biology is relaunching under a new name that better reflects its vision of bringing Stanford's unique interdisciplinary culture to bear at a new frontier of chemistry.

Companies are using an electron-beam 3-D printing process to manufacture medical implants.

Five years ago, the brightest source of X-rays on the planet lit up at SLAC. The Linac Coherent Light Source (LCLS) X-ray laser's scientific and technical progress since its momentous "first light" have been no less luminous, say those who...

A new tool for analyzing mountains of data from SLAC’s Linac Coherent Lightsource (LCLS) X-ray laser can produce high-quality images of important proteins using fewer samples. Scientists hope to use it to reveal the structures and functions of proteins that...

New Technology Allows Faster, More Accurate Imaging of Hard-to-study Membrane Proteins

Two SLAC physicists with decades of particle accelerator experience helped a Silicon Valley company design and build X-ray devices that scan cargo containers for nuclear materials and other hazards.

Last year's Nobel Prize in Chemistry – shared by Stanford School of Medicine Professor Brian Kobilka and Robert Lefkowitz of Duke University – recognized groundbreaking research in G protein-coupled receptors (GPCRs).